Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.
2.
3.
7.

Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.

Valcárcel R, Holz H, Jiménez CG, Barettino D, Stunnenberg HG.

Genes Dev. 1994 Dec 15;8(24):3068-79.

10.

RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.

Furnari FB, Zacny V, Quinlivan EB, Kenney S, Pagano JS.

J Virol. 1994 Mar;68(3):1827-36.

11.

Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha.

Tate BF, Allenby G, Janocha R, Kazmer S, Speck J, Sturzenbecker LJ, Abarzúa P, Levin AA, Grippo JF.

Mol Cell Biol. 1994 Apr;14(4):2323-30.

12.

Expression of retinoid X receptors and COUP-TFI in a human salivary gland adenocarcinoma cell line.

Kyakumoto S, Nemoto T, Sato N, Ota M.

Biochem Cell Biol. 1997;75(6):749-58.

PMID:
9599664
13.

Efficient transactivation by retinoic acid receptors in yeast requires retinoid X receptors.

Heery DM, Zacharewski T, Pierrat B, Gronemeyer H, Chambon P, Losson R.

Proc Natl Acad Sci U S A. 1993 May 1;90(9):4281-5.

15.

Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC.

Nucleic Acids Res. 1993 Jul 11;21(14):1999-2007.

16.

Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene.

Kirfel J, Kelter M, Cancela LM, Price PA, Schüle R.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2227-32.

18.
19.

Supplemental Content

Support Center